Cargando…

Deep-learning and MR images to target hypoxic habitats with evofosfamide in preclinical models of sarcoma

Rationale: Hypoxic regions (habitats) within tumors are heterogeneously distributed and can be widely variant. Hypoxic habitats are generally pan-therapy resistant. For this reason, hypoxia-activated prodrugs (HAPs) have been developed to target these resistant volumes. The HAP evofosfamide (TH-302)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jardim-Perassi, Bruna V., Mu, Wei, Huang, Suning, Tomaszewski, Michal R., Poleszczuk, Jan, Abdalah, Mahmoud A., Budzevich, Mikalai M., Dominguez-Viqueira, William, Reed, Damon R., Bui, Marilyn M., Johnson, Joseph O., Martinez, Gary V., Gillies, Robert J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8039958/ https://www.ncbi.nlm.nih.gov/pubmed/33859749 http://dx.doi.org/10.7150/thno.56595

Ejemplares similares

Quantitative imaging of cancer in the postgenomic era: Radio(geno)mics, deep learning, and habitats
por: Napel, Sandy, et al.
Publicado: (2018)

In Vivo Imaging of Rat Vascularity with FDG-Labeled Erythrocytes
por: Wang, Shaowei, et al.
Publicado: (2022)

Intraperitoneal Delivery of Iopamidol to Assess Extracellular pH of Orthotopic Pancreatic Tumor Model by CEST-MRI
por: Jardim-Perassi, Bruna Victorasso, et al.
Publicado: (2023)

Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations
por: Bailleul, Quentin, et al.
Publicado: (2021)

In vivo positron emission tomographic blood pool imaging in an immunodeficient mouse model using 18F-fluorodeoxyglucose labeled human erythrocytes
por: Choi, Jung W., et al.
Publicado: (2019)

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
por: Nytko, Katarzyna J., et al.
Publicado: (2017)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Evofosfamide for the treatment of human papillomavirus-negative head and neck squamous cell carcinoma
por: Jamieson, Stephen M.F., et al.
Publicado: (2023)

Efficacy of the hypoxia-activated prodrug evofosfamide (TH-302) in nasopharyngeal carcinoma in vitro and in vivo
por: Huang, Yan, et al.
Publicado: (2018)

Hypoxia-Targeting Drug Evofosfamide (TH-302) Enhances Sunitinib Activity in Neuroblastoma Xenograft Models()
por: Kumar, Sushil, et al.
Publicado: (2018)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide (TH‐302) in osteolytic breast cancer murine models
por: Liapis, Vasilios, et al.
Publicado: (2016)

Anticancer efficacy of the hypoxia‐activated prodrug evofosfamide is enhanced in combination with proapoptotic receptor agonists against osteosarcoma
por: Liapis, Vasilios, et al.
Publicado: (2017)

Targeting Hypoxia Using Evofosfamide and Companion Hypoxia Imaging of FMISO-PET in Advanced Biliary Tract Cancer
por: Yoon, Jeesun, et al.
Publicado: (2021)

Phase 2 trial of hypoxia activated evofosfamide (TH302) for treatment of recurrent bevacizumab-refractory glioblastoma
por: Brenner, Andrew J., et al.
Publicado: (2021)

Impact of Tumour Hypoxia on Evofosfamide Sensitivity in Head and Neck Squamous Cell Carcinoma Patient-Derived Xenograft Models
por: Harms, Julia K., et al.
Publicado: (2019)

Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models
por: Stokes, Ashley M., et al.
Publicado: (2016)

Circulating metabolites associated with tumor hypoxia and early response to treatment in bevacizumab-refractory glioblastoma after combined bevacizumab and evofosfamide
por: Lodi, Alessia, et al.
Publicado: (2022)

A Monte Carlo Method for Determining the Response Relationship between Two Commonly Used Detectors to Indirectly Measure Alpha Particle Radiation Activity
por: Tichacek, Christopher J., et al.
Publicado: (2019)

Variability of Image Features Computed from Conventional and Respiratory-Gated PET/CT Images of Lung Cancer
por: Oliver, Jasmine A., et al.
Publicado: (2015)

Evaluation of radiofluorinated carboximidamides as potential IDO-targeted PET tracers for cancer imaging
por: Huang, Xuan, et al.
Publicado: (2017)

An Intratumor Pharmacokinetic/Pharmacodynamic Model for the Hypoxia-Activated Prodrug Evofosfamide (TH-302): Monotherapy Activity is Not Dependent on a Bystander Effect()()
por: Hong, Cho Rong, et al.
Publicado: (2018)

Predictive computational modeling to define effective treatment strategies for bone metastatic prostate cancer
por: Cook, Leah M., et al.
Publicado: (2016)

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug‐Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide
por: Lüpfert, Christian, et al.
Publicado: (2018)

A Combination of Radiation and the Hypoxia-Activated Prodrug Evofosfamide (TH-302) is Efficacious against a Human Orthotopic Pancreatic Tumor Model()()
por: Hajj, Carla, et al.
Publicado: (2017)

Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, Andres N., et al.
Publicado: (2018)

Erratum: Predicting clinically significant prostate cancer using DCE-MRI habitat descriptors
por: Parra, N. Andres, et al.
Publicado: (2019)

Recurrent Aneurysmal Bone Cyst of the Distal Fibula Treated with Denosumab and Curettage
por: Fontenot, Philip B., et al.
Publicado: (2018)

Wee1 Inhibition by MK-1775 Leads to Tumor Inhibition and Enhances Efficacy of Gemcitabine in Human Sarcomas
por: Kreahling, Jenny M., et al.
Publicado: (2013)

(18)F-FMISO PET Imaging Identifies Hypoxia and Immunosuppressive Tumor Microenvironments and Guides Targeted Evofosfamide Therapy in Tumors Refractory to PD-1 and CTLA-4 Inhibition
por: Reeves, Kirsten M., et al.
Publicado: (2022)

A phase 1 ‘window-of-opportunity’ trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients
por: Larue, Ruben T. H. M., et al.
Publicado: (2016)

Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization
por: Pandya, Darpan N., et al.
Publicado: (2016)

HET0016, a Selective Inhibitor of 20-HETE Synthesis, Decreases Pro-Angiogenic Factors and Inhibits Growth of Triple Negative Breast Cancer in Mice
por: Borin, Thaiz Ferraz, et al.
Publicado: (2014)

Neuroretinal hypoxic signaling in a new preclinical murine model for proliferative diabetic retinopathy
por: Wert, Katherine J, et al.
Publicado: (2016)

Modelling Blood Flow and Metabolism in the Preclinical Neonatal Brain during and Following Hypoxic-Ischaemia
por: Caldwell, Matthew, et al.
Publicado: (2015)

Stem Cell Therapy for Neonatal Hypoxic-Ischemic Encephalopathy: A Systematic Review of Preclinical Studies
por: Serrenho, Inês, et al.
Publicado: (2021)

Connexin 43 Is a Potential Prognostic Biomarker for Ewing Sarcoma/Primitive Neuroectodermal Tumor
por: Bui, Marilyn M., et al.
Publicado: (2011)

Presence of human breast cancer xenograft changes the diurnal profile of amino acids in mice
por: Junior, Rubens Paula, et al.
Publicado: (2022)

Osteosarcoma in Pediatric Patients and Young Adults: A Single Institution Retrospective Review of Presentation, Therapy, and Outcome
por: Haddox, Candace L., et al.
Publicado: (2014)

Neonatal Hypoxic-Ischemic Encephalopathy Yields Permanent Deficits in Learning Acquisition: A Preclinical Touchscreen Assessment
por: Maxwell, Jessie R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p8bj1sb7j04c8j7kklhqmmgfcg